SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5
http://www.w3.org/2000/01/rdf-schema#comment
"Characterizing the expression of PTEN AKT and pS6 Ser235/236 might be a useful predictive tool for deciding whether to use mTOR inhibitors to treat conjunctiva melanomas."
xsd:string
http://purl.uniprot.org/uniprot/#_AB067C82DD49A4F6C0788A2EA118EACFA9292E344C380C103418BBC3AC8746F938540B2196AE45C43E266777947DE8B4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5
http://purl.uniprot.org/uniprot/P23443
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5
http://purl.uniprot.org/uniprot/#_P23443-mappedCitation-20173664
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/698A0C4BA0D7212B4B16376FCD6900B9E2AD6A505EFAC81B621F4188017666366768031FD8C686FCA73E83208806D4C5